Pope Leo XIV will undergo surgery this week after a nodular lesion was found in his lung, the Vatican said. Recovery is ...

(9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study ...

Morrison and Fulton have a long and storied history on the football field. This year, the conference rivals are coming ...

Abdominal pain or changes in bowel habits should not be ignored simply because someone is young. They could be signs of a ...

All four patients with early-stage rectal cancer who still had circulating tumor DNA (ctDNA) in their blood after ...

On October 10, Akeso announced that the first patient had been dosed in COMPASSION-40, a Phase III study of cadonilimab as a ...

Phase III trial of cadonilimab begins in perioperative colon cancer, testing dual PD-1/CTLA-4 blockade in MSI-H/dMMR patients ...

The FDA approves Roche’s Tecentriq with chemotherapy for stage III dMMR colon cancer after a trial showed a 50% reduction in ...

Akeso, Inc. announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as ...

The FDA has approved atezolizumab with chemotherapy after surgery for stage III colon cancer with deficient mismatch repair, ...

A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific ...